Black Lives Matter has elevated the conversation on racial and ethnic disparities. Despite recent focus within ATS on populations at risk for health care disparities, research tools to understand the impact of race as more than a scientific variable are underdeveloped. This session seeks to apply these principles to pediatric lung disease. By understanding the impact of race on the clinical care and outcomes of infants and children with sickle cell disease, bronchopulmonary dysplasia, and pulmonary hypertension, the pediatric pulmonary community may be able to apply these approaches and make progress in reducing pediatric respiratory health disparities.
CME credits and/or Certificates of Completion are not provided for this session.
1- Understand the use of race as a variable in pediatric research studies
2- Identify populations at risk for health disparities across several pediatric pulmonary diseases
3- Integrate new strategies in clinical practice and research that will have the effect of closing the disparity gap for children in the US and globally
Paul E. Moore, MD, ATSF: Focus on Racial Disparities by the ATS Pediatrics Assembly
Kim Smith-Whitley, MD: Racial Healthcare Disparities in Sickle Cell Disease
Rita M. Ryan, MD, ATSF: Racial Disparities in Bronchopulmonary Dysplasia
Eric D. Austin, MD, MSc: Racial Disparities in Pediatric Pulmonary Hypertension
Robin R. Deterding, MD: Strategies in Addressing Racial Disparities in Pediatric Pulmonary Disease
You can save 20% today by joining the ATS.Join more than 16,000 healthcare providers and researchers as a member of the American Thoracic Society today. As an ATS member, you’ll gain access to cutting-edge science, collaboration opportunities, discounts on the annual ATS International Conference, and resources to share with patients. The ATS offers multiple ways to get involved, from Assembly membership to in-person networking opportunities, as well as an online community offered through DocMatter. Join the ATS Today!